Carl Zeiss Meditec AG

Carl Zeiss Meditec AG was founded in 2002 but dates back to 1846, and is headquartered in Jena, Germany. This medical technology company offers a wide range of solutions, mostly in the visualisation arena, to diagnose and treat ophthalmic diseases, focusing on the field of microsurgery. The company’s technology is future-oriented and involves innovative solutions such as intraoperative radiotherapy. Solutions offered by the company include comprehensive packages for both the diagnosis and treatment of ophthalmic diseases, including implants and consumables. Carl Zeiss Meditec AG operates in various locations around the world, including France, Germany, Japan, Spain, Turkey, the UK and the US. The company also has Research and Development Centres in China and India. Overall, the company employs about 3,050 employees worldwide, including around 400 in its headquarters in Jena. Carl Zeiss Meditec AG is the parent company of a number of subsidiaries such as Carl Zeiss Meditec group, Carl Zeiss Meditec Inc., Carl Zeiss Meditec Iberia S.A., and others. During the fiscal year, 2017/18, Carl Zeiss Meditec AG reported revenue of €1,280.9 million. Learn more about this instrument and buy AFX.DE stocks.